BSE filing, NSE: AARTIPHARM. Summary written from the filing by ALFA Finder's alert engine.
Aarti Pharmalabs Ltd: key numbers
- Share price
- ₹872.70
- Market cap
- ₹7,914 Cr
- Revenue (annual)
- ₹1,819 Cr
- Net profit (annual)
- ₹174.7 Cr
- P/E (TTM)
- 30.8×Sector 45.9×
- Promoter holding
- 39.66%-3.20% QoQ
- FII holding
- 8.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Pharmalabs Ltd
All →Aarti Pharmalabs Earnings Call Transcript: Key Takeaways
Aarti Pharmalabs delivered record quarterly revenue driven by strong CDMO growth, though aggressive capex is temporarily elevating debt and working capital.
- Call
- Guides 45% growth
Aarti Pharmalabs Investor Presentation: Key Takeaways
Q2 FY27 standalone revenue INR 6,126Mn (+46.8% YoY), EBITDA INR 1,358Mn (22.2% margin), PAT INR 658Mn (+180% YoY). H1 revenue +44.7%. Xanthine capacity expansion and Atali capex drive growth.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
Aarti Pharmalabs Q2 FY27 Results: Net Profit ₹71.5 Cr, Up 248.8% YoY
Aarti Pharmalabs Ltd reported revenue from operations of ₹610.5 Cr (+45.9% YoY) and net profit of ₹71.5 Cr (+248.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹71.5 Cr · +248.8% YoY
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
Other production started announcements
All →Gala Precision Engineering Production Started
Gala Precision Engineering commissioned a 1.20 MW open access solar plant at Nanded on October 30, 2026. The plant will supply captive power to its manufacturing facility.
- solar power capacity
- 1.2 MW
Waaree Energies Production Started
Waaree Solar Americas commenced commercial production of 1.6 GW solar modules at Brookshire, Texas. Total facility capacity now stands at 3.2 GW.
- solar module manufacturing capacity
- 1600 MW
Studds Accessories Production Started
Studds Accessories commenced commercial production at its Manufacturing Facility-V in Faridabad on October 30, 2026, after receiving Consent to Operate. No capacity or monetary value was disclosed.
NTPC Green Energy Production Started
NTPC Green Energy's subsidiary declared commercial operations for 95.6 MW of its Kalasar Solar Energy Project effective October 30, 2026.
- solar capacity
- 95.6 MW
NTPC Production Started
NTPC's subsidiary NVVN declared its first 250 MW / 500 MWh BESS project commercial from 27 October 2026, with power scheduling starting 28 October. This is a commercial operation start for a new energy storage asset.
- battery energy storage capacity
- 250.0 MW
DCM Shriram Production Started
DCM Shriram announced full commissioning of its ~68 MW wind-solar hybrid renewable power project. The project is held through SPV JSW Renew Energy Thirty Two Limited.
- wind-solar hybrid renewable power capacity
- 68.0 MW